Schedule 13D ownership disclosure
MERSANA THERAPEUTICS INC
Security class unavailable · CUSIP: 59045L106
Event date: 2022-02-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-22-031107
- Form type
- SC 13D
- Filer
- Bain Capital Life Sciences Fund II, L.P.
- CIK
- CIK 1773187
- Filed
- Feb 08, 2022
- Reporting period
- Feb 07, 2022
- Description
- Schedule 13D beneficial ownership